The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Factors related to men’s experience with prostate cancer germline testing.
 
Veda N. Giri
Stock and Other Ownership Interests - Novopyxis (I)
Honoraria - Ambry Genetics
 
Laura Gross
No Relationships to Disclose
 
Rebecca Hartman
No Relationships to Disclose
 
Amy Leader
No Relationships to Disclose
 
Young E. Whang
No Relationships to Disclose
 
Anna Couvillon
No Relationships to Disclose
 
Heather H. Cheng
Consulting or Advisory Role - AstraZeneca; AstraZeneca (I)
Research Funding - Clovis Oncology (Inst); Color Genomics Foundation (Inst); Janssen (Inst); Medivation/Astellas (Inst); Phosplatin Therapeutics (Inst); Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate
Other Relationship - Janssen
 
Channing Judith Paller
Consulting or Advisory Role - Dendreon; Exelixis; Omnitura
Research Funding - Lilly (Inst)
 
Stacy Loeb
Stock and Other Ownership Interests - Gilead Sciences (I)
 
Lawrence Ivan Karsh
Stock and Other Ownership Interests - Swan Valley Medical (I)
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Dendreon; Janssen; Merck; Pfizer
Consulting or Advisory Role - Abbvie; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb/Roche; Dendreon; Ferring; Janssen; Merck; Pfizer
Speakers' Bureau - Astellas Pharma; AstraZeneca; Bayer; Dendreon; Janssen; Myovant Sciences; Pfizer
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bioxell Pharma (Inst); Bristol-Myers Squibb/Sanofi (Inst); Dendreon (Inst); Exact Sciences (Inst); Ferring (Inst); FKD Therapies (Inst); Genomic Health (Inst); Hinova Pharmaceuticals (Inst); Janssen (Inst); KDx Diagnostics (Inst); Merck (Inst); Myovant Sciences (Inst); Pfizer (Inst); Tavanta Therapeutics (Inst); Vaxiion (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Bayer; dendreon; Janssen; Pfizer
 
Sue J. Friedman
Travel, Accommodations, Expenses - Eisai
 
Tomasz M. Beer
Employment - Exact Sciences
Stock and Other Ownership Interests - Arvinas; Exact Sciences; Salarius Pharmaceuticals
Consulting or Advisory Role - Abbvie; Amgen; Arvinas; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Constellation Pharmaceuticals; Dantari Pharmaceuticals; GlaxoSmithKline; GRAIL; Janssen; Pfizer; Sanofi; Sapience Therapeutics
Research Funding - Alliance Foundation Trials (Inst); Astellas Pharma (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Corcept Therapeutics (Inst); Endocyte (Inst); Freenome (Inst); GRAIL (Inst); Harpoon Therapeutics (Inst); Janssen Research & Development (Inst); Medivation (Inst); Sotio (Inst); Theraclone Sciences (Inst); Zenith Epigenetics (Inst)
 
Alexandra Sokolova
No Relationships to Disclose
 
Scott W. Keith
No Relationships to Disclose